INTERNATIONAL PATENT: PRIDGEN, WILLIAM LANGLEY FILES APPLICATION FOR "VALACYCLOVIR AND CELECOXIB IN COMBINATION WITH NIRMATRELVIR AND RITONAVIR FOR THE TREATMENT OF COVID-19"

GENEVA, June 19 -- PRIDGEN, William Langley (6300 Lake Vista DriveTuscaloosa, Alabama 35406) filed a patent application (PCT/US2024/058782) for "VALACYCLOVIR AND CELECOXIB IN COMBINATION WITH NIRMATRELVIR AND RITONAVIR FOR THE TREATMENT OF COVID-19" on Dec 06, 2024. With publication no. WO/2025/122814, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PRIDGEN, William Langley (6300 Lake Vista DriveTuscaloosa, Alabama 35406)

Abstract: The present disclosure relates to methods of diseases and/or conditions associated with ...